Tumor‐Specific Protein Induced in Situ Self‐Assembly of Peptide Drugs for Synergistic Mitochondria Disruption

Mitochondria‐targeted cancer therapy is an effective method for controlling tumor growth. However, the presence of repair mechanisms in tumor cells in response to mitochondrial damage poses significant challenges for treatment. By taking advantage of intracellular self‐assembly technology, a peptide...

Full description

Saved in:

Bibliographic Details
Published in:	Advanced materials (Weinheim) Vol. 37; no. 3; p. e2413069
Main Authors:	Hao, Yi, Hou, Da‐Yong, Zhou, Lei, Fan, Yan‐Lei, Wu, Xiu‐Hai, Liu, Yi‐Xuan, Xu, Yin‐Sheng, Song, Ben‐Li, Yi, Li, Qiao, Zeng‐Ying, Wang, Hao, Xu, Shou‐Ping
Format:	Journal Article
Language:	English
Published:	Germany Wiley Subscription Services, Inc 01.01.2025
Subjects:	Animals Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Cell Line, Tumor Cell membranes Control methods Damage Dimerization Disruption Drugs Epithelial-Mesenchymal Transition - drug effects Humans Mice Mitochondria Mitochondria - drug effects Mitochondria - metabolism Mucin-1 - chemistry Mucin-1 - metabolism Nanomaterials NF-kappa B - metabolism Peptides Peptides - chemistry Peptides - pharmacology Peptides - therapeutic use Reactive Oxygen Species - metabolism Self-assembly Tumors peptide nanomaterials synergy mitochondrial self‐assembly
ISSN:	0935-9648, 1521-4095, 1521-4095
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!